Evaluation of the mutagenic activity of hydroxyurea on the G1-S-G2 phases of the cell cycle: An in vitro study

Genetics and Molecular Research

Volumn 2, Issue 3, 2003, Pages 328-333

  De Lima, Patrícia Danielle Lima ^a   Dos Santos Cardoso, Plínio Cerqueira ^a   Khayat, André Salim ^a   De Oliveira Bahia, Marcelo ^a   Rodríguez Burbano, Rommel ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Chromosome aberrations; Hydroxyurea; Mitotic index; Sickle cell anemia

Indexed keywords

HYDROXYUREA; RIBONUCLEOTIDE REDUCTASE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; MALE; MITOSIS INDEX; MUTAGENIC ACTIVITY; SICKLE CELL ANEMIA; ANALYSIS OF VARIANCE; BIOASSAY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; INTERPHASE; LYMPHOCYTE; METHODOLOGY; MUTAGEN TESTING;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CHROMOSOME ABERRATIONS; ENDPOINT DETERMINATION; G1 PHASE; G2 PHASE; HUMANS; HYDROXYUREA; INTERPHASE; LYMPHOCYTES; MITOTIC INDEX; MUTAGENICITY TESTS; S PHASE;

EID: 2542507299     PISSN: 16765680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Antunes, L.M.G. and Takahashi, C.S. (1998). Effect of high doses of vitamins C and E against chromosomal damage induced by doxorubicin in rat bone marrow cells. Mutat. Res. 419: 137-143.
2. Ayres, M., Ayres Jr., M., Ayres, D.L. and Santos, A.S. (2000a). Uma amostra. In: BioEstat 2.0 Aplicações Estatísticas nas Áreas das Ciências Biológicas e Médicas (Sociedade Civil Mamirauá, CNPq, eds.). Belém, Sociedade Civil Mamirauá, CNPq, Brasília, DF, Brazil, pp. 77-87.
3. Ayres, M., Ayres Jr., M., Ayres, D.L. and Santos, A.S. (2000b). Duas amostras relacionadas. In: BioEstat 2.0 Aplicações Estatísticas nas Áreas das Ciências Biológicas e Médicas (Sociedade Civil Mamirauá, CNPq, eds.). Belém, Sociedade Civil Mamirauá, CNPq, Brasília, DF, Brazil, pp. 107-115.
4. Donehower, R.C. (1992). An overview of the clinical experience with hydroxyurea. Semin. Oncol. 19: 11-19.
5. Hanft, V.N., Fruchtman, S.R., Pickens, C.V., Rosse, W.F., Howard, T.A. and Ware, R.E. (2000). Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood 95: 3589-3593.
6. Janossy, G. and Greaves, M.F. (1972). Lymphocyte activation. II. Discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera. Clin. Exp. Immunol. 10: 525-536.
7. Kennedy, B.J. (1992). The evolution of hydroxyurea therapy in chronic myelogenous leukemia. Semin. Oncol. 19: 21-26.
8. Lindenhahn, M. and Schubert, I. (1983). On the origin of hydroxyurea-induced chromatid aberrations in G2 chromosomes with BrdUrd in only one of the sister chromatids. Murar. Res. 108: 301-316.
9. Moorhead, P.S., Nowell, P.C., Mellmam, W.J., Battips, D.M. and Hungerford, D.A. (1960). Chromosome preparations of leukocytes culmred from human peripheral blood. Exp. Cell. Res. 20: 613-616.
10. Preston, R.J., San Sebastian, J.R. and McFee, A.F. (1987). The in vitro human lymphocyte assay for assessing the clastogenicity of chemical agents. Murar. Res. 189: 175-183.
11. Sanchez, P.S., Gomes, R.A., Takahashi, C.S. Rodrigues, M.A.R., Rabello-Gay, M.N., Ribeiro, L.R., Ferrari, I., Pereira, C.A.B., Varella-Garcia, M., Almeida, T.M.B., Andrade, H.H.R., Reguly, M.L. and Marques, E.K. (1991). Mutagênese. in: Mutagênese, Teratogênese e Carcinogênese (Rabello-Gay, M.N., Rodrigues, M.A.R. and Monteleone-Neto, R., eds.). Sociedade Brasileira de Genética, Ribeirão Preto, SP, Brazil, pp. 11-167.
12. Yarbro, J.W. (1992). Mechanism of action of hydroxyurea. Semin. Oncol. 19: 1-10.